The CEO's open-market buy after earnings is a modest confidence signal, but the dollar amount is too small to drive stock movement. Monitor for any larger insider accumulation or changes in institutional ownership. The Q2 earnings beat and raised guidance are the more material catalysts.
Price Chart
Executive Summary
Two Elevance Health insiders, including CEO Gail Boudreaux, made open-market purchases totaling $1.37M over two days following the Q2 2026 earnings release. The CEO bought $1.0M worth of shares, and a director bought $366K. However, the total purchase amount represents only ~0.0017% of ELV's $81B market cap, making it a trivial signal.
Key Financial Metrics
Key Facts
- CEO Gail Boudreaux purchased 2,725 shares at ~$367.50 avg, totaling $1,002,230
- Director Ramiro G. Peru purchased 1,000 shares at $366.05, totaling $366,050
- Total insider purchases: $1,368,280, or 0.0017% of $81B market cap
- Purchases occurred 2 days after Q2 2026 earnings (EPS beat by 20%, but revenue growth flat and margins compressed)
Financial Impact
Insider purchases of $1.37M are negligible relative to $81B market cap; no material financial impact
Risk Factors
- Insider buying is trivial in size and may not reflect a strong conviction signal
- Q2 earnings showed declining GAAP EPS (-13% YoY) and margin compression, which could weigh on the stock
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ELV-1784316092275 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | 8-K | $416.54 $414.26 | ▼ −0.55% | ▼ −0.05% | $381.34 (−8.45%) |
Aug 27, 2026 5w ago | Institutional Cluster | $399.11 $414.78 | ▲ +3.93% | ▲ +3.66% | $381.34 (−4.45%) |
Aug 20, 2026 6w ago | Court Ruling | $396.28 $399.11 | ▲ +0.71% | ▼ −0.40% | $381.34 (−3.77%) |
Aug 17, 2026 6w ago | Court Ruling | $390.24 $402.63 | ▲ +3.17% | ▲ +4.37% | $381.34 (−2.28%) |
Jul 17, 2026 10w ago | Insider Cluster | $373.11 $379.31 | ▲ +1.66% | ▲ +2.35% | $381.34 (+2.21%) |
Jul 15, 2026 11w ago | 8-K | $390.33 $389.09 | ▼ −0.32% | ▲ +0.66% | $381.34 (−2.30%) |
Jun 15, 2026 15w ago | Insider Cluster | $397.80 $395.10 | ▼ −0.68% | ▲ +1.55% | $381.34 (−4.14%) |
Jun 10, 2026 16w ago | 8-K | $404.56 $397.80 | ▼ −1.67% | ▼ −5.10% | $381.34 (−5.74%) |
Apr 22, 2026 23w ago | 8-K | $328.20 $368.75 | ▼ −12.36% | ▼ −12.30% | $381.34 (−16.19%) |
Mar 27, 2026 26w ago | DEFA14A | $284.79 $311.83 | ▲ +9.49% | ▲ +5.19% | $381.34 (+33.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access